95 related articles for article (PubMed ID: 29471321)
21. Role of endothelial heparanase in delayed-type hypersensitivity.
Edovitsky E; Lerner I; Zcharia E; Peretz T; Vlodavsky I; Elkin M
Blood; 2006 May; 107(9):3609-16. PubMed ID: 16384929
[TBL] [Abstract][Full Text] [Related]
22. Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors.
Hunter KE; Palermo C; Kester JC; Simpson K; Li JP; Tang LH; Klimstra DS; Vlodavsky I; Joyce JA
Oncogene; 2014 Apr; 33(14):1799-808. PubMed ID: 23644656
[TBL] [Abstract][Full Text] [Related]
23. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
[TBL] [Abstract][Full Text] [Related]
24. Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced Diabetes.
Zhang D; Wang F; Lal N; Chiu AP; Wan A; Jia J; Bierende D; Flibotte S; Sinha S; Asadi A; Hu X; Taghizadeh F; Pulinilkunnil T; Nislow C; Vlodavsky I; Johnson JD; Kieffer TJ; Hussein B; Rodrigues B
Diabetes; 2017 Jan; 66(1):45-57. PubMed ID: 27999107
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of heparanase in overt diabetic nephropathy.
van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
[TBL] [Abstract][Full Text] [Related]
26. Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.
Planer D; Metzger S; Zcharia E; Wexler ID; Vlodavsky I; Chajek-Shaul T
PLoS One; 2011 Apr; 6(4):e18370. PubMed ID: 21483695
[TBL] [Abstract][Full Text] [Related]
27. Heparanase cooperates with Ras to drive breast and skin tumorigenesis.
Boyango I; Barash U; Naroditsky I; Li JP; Hammond E; Ilan N; Vlodavsky I
Cancer Res; 2014 Aug; 74(16):4504-14. PubMed ID: 24970482
[TBL] [Abstract][Full Text] [Related]
28. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
29. Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model.
Cheng X; Jia J; Zhang T; Zhang X; Vlodavsky I; Li JP
Cells; 2022 Jun; 11(13):. PubMed ID: 35805119
[TBL] [Abstract][Full Text] [Related]
30. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
31. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
32. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS.
Wang L; Huang X; Kong G; Xu H; Li J; Hao D; Wang T; Han S; Han C; Sun Y; Liu X; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(2):669-75. PubMed ID: 27498004
[TBL] [Abstract][Full Text] [Related]
33. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
34. The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target.
Khamaysi I; Singh P; Nasser S; Awad H; Chowers Y; Sabo E; Hammond E; Gralnek I; Minkov I; Noseda A; Ilan N; Vlodavsky I; Abassi Z
Sci Rep; 2017 Apr; 7(1):715. PubMed ID: 28386074
[TBL] [Abstract][Full Text] [Related]
35. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.
Abassi Z; Hamoud S; Hassan A; Khamaysi I; Nativ O; Heyman SN; Muhammad RS; Ilan N; Singh P; Hammond E; Zaza G; Lupo A; Onisto M; Bellin G; Masola V; Vlodavsky I; Gambaro G
Oncotarget; 2017 May; 8(21):34191-34204. PubMed ID: 28388547
[TBL] [Abstract][Full Text] [Related]
36. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
37. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
38. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
39. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
[TBL] [Abstract][Full Text] [Related]
40. Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells.
Maccarana M; Jia J; Li H; Zhang X; Vlodavsky I; Li JP
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
